The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, October 09, 2024
Aptar Pharma has acquired all device technology assets from the proprietary portfolio of SipNose Nasal Delivery Systems, a company focused on ...
read more
Datwyler has announced the expansion of its NeoFlex™ range of coated plungers with new sizes for containers aimed at large-volume auto-injectors and ...
read more
Medicines for Malaria Venture (MMV) and Quotient Sciences have begun the first clinical trial for a long-acting injectable (LAI) preventive compound ...
read more
Wednesday, November 13, 2024
Continuity Biosciences, a new bioscience company dedicated to developing and commercializing technologies for cell reprogramming, immune modulation, ...
read more
Thursday, November 14, 2024
Merck and LaNova Medicines Ltd. announced an exclusive global license to develop, manufacture and commercialize LM-299, a novel investigational PD-1/...
read more
Monday, November 18, 2024
Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, announced a strategic collaboration with AstraZeneca to develop AI-...
read more
Tuesday, November 26, 2024
Dr. Reddy's Laboratories, Inc. and Senores Pharmaceuticals, Inc. announced the launch of Ivermectin Tablets USP, 3 mg, which is bioequivalent and ...
read more
Friday, December 06, 2024
Valisure and Picket Pharmaceuticals announced a strategic partnership to integrate Valisure's independent chemical analysis and certification program ...
read more
Thursday, December 12, 2024
Neuraxpharm Group and Pharmathen announced a strategic alliance to co-develop new long-acting injectable therapies within the psychiatry field under ...
read more
Wednesday, December 18, 2024
Fresenius Kabi announced that Epinephrine Injection, USP, is now available in the United States as the first generic version of Epinephrine in a 1mg/...
read more
Wednesday, January 08, 2025
Merck announced that the National Medical Products Administration (NMPA) of China approved GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, ...
read more
Thursday, January 09, 2025
Oxford BioTherapeutics announced that Boehringer Ingelheim has exercised an option for rights to a fourth novel oncology target from an ongoing ...
read more
Wednesday, January 15, 2025
The FDA’s Rare Disease Innovation Hub (the Hub) has released its Strategic Agenda, which outlines the actions the Hub plans to undertake during its ...
read more
Thursday, January 16, 2025
Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved Omvoh® (mirikizumab-mrkz) for the treatment of ...
read more
Wednesday, January 29, 2025
Ocean Biomedical announced that its Scientific Co-founder, Dr. Jonathan Kurtis, MD, PhD, and his research team have received additional significant ...
read more